Robyn Levine, Ph.D.

2008 Astrophysical and Planetary Sciences University of Colorado, Boulder, Boulder, CO, United States 
Astronomy and Astrophysics
"Robyn Levine"
Mean distance: 3992.86


Sign in to add mentor
Andrew J. S. Hamilton grad student 2008 CU Boulder
 (Simulating the growth of a disk galaxy and its supermassive black hole in a cosmological context.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Heimbruch KE, Fisher JB, Stelloh CT, et al. (2021) DOT1L inhibitors block abnormal self-renewal induced by cohesin loss. Scientific Reports. 11: 7288
Miles LA, Bowman RL, Merlinsky TR, et al. (2020) Single-cell mutation analysis of clonal evolution in myeloid malignancies. Nature
Pastore F, Krishnan A, Hammarén HM, et al. (2020) JAK2S523L, a novel gain-of-function mutation in a critical autoregulatory residue in JAK2V617F- MPNs. Blood Advances. 4: 4554-4559
Miles LA, Bowman RL, Merlinsky TR, et al. (2019) Single Cell DNA Sequencing Identifies Combinatorial Mutation Patterns and Clonal Architecture in Myeloid Malignancies Blood. 134: 913-913
Pronier E, Bowman RL, Ahn J, et al. (2018) Genetic and epigenetic evolution as a contributor to WT1-mutant leukemogenesis. Blood
McKenney AS, Lau AN, Somasundara AVH, et al. (2018) JAK2/IDH-mutant-driven myeloproliferative neoplasm is sensitive to combined targeted inhibition. The Journal of Clinical Investigation
Santos FP, Getta B, Masarova L, et al. (2018) Prognostic Impact of Activating Mutations of the NRAS/KRAS Genes in Patients with Primary and Post-Essential Thrombocythemia (ET)/Polycythemia Vera (PV) Myelofibrosis (MF) Blood. 132: 1756-1756
Spitzer B, Gundem G, Farnoud N, et al. (2018) Early Detection and Molecular Characterization of Therapy-Related Leukemia in Children Reveals Patterns of Disease Transformation and Guides Future Surveillance Protocols Blood. 132: 291-291
Xiao W, Goldberg AD, Ball B, et al. (2018) PHF6 Mutations Are Mutually Exclusive to TP53 Mutations, and Define a Distinct Subgroup of Secondary Acute Myeloid Leukemia Associated with a Primitive Stem/Progenitor Immunophenotype, Absent Complex Karyotype and Relatively Better Outcomes Blood. 132: 2788-2788
Meyer AE, Stelloh C, Fisher JB, et al. (2018) Combinatorial Genetics Uncovers Novel Targets for the Treatment of Npm1/Cohesin Mutated AML Blood. 132: 2598-2598
See more...